D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Walt Disney
DIS
|
+$410M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
GE Aerospace
GE
|
+$196M |
| 5 |
Dell
DELL
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$374M |
| 2 |
PayPal
PYPL
|
+$289M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Nike
NKE
|
+$227M |
| 5 |
Amgen
AMGN
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kratos Defense & Security Solutions
KTOS
$9.27B
| $2.88M | 0.01% |
417,301
+277,226
| +198% | +$1.62M |
|
1627
Theravance Biopharma
TBPH
$874M
| $2.87M | 0.01% |
79,305
+22,226
| +39% | +$619K |
|
1628
CALL
Hershey
HSY
$36.6B
| $2.87M | 0.01% |
30,000
-2,000
| -6% | -$212K |
|
|
1629
PUT
Hershey
HSY
$36.6B
| $2.87M | 0.01% |
30,000
| – | – |
|
|
AMTD
1630
CALL
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.86M | 0.01% |
81,100
| – | – |
|
1631
Cytokinetics
CYTK
$10.9B
| $2.85M | 0.01% |
310,959
+6,279
| +2% | +$65.6K |
|
|
JOY
1632
PUT
DELISTED
Joy Global Inc
JOY
| $2.85M | 0.01% |
102,900
| – | – |
|
1633
CALL
A.O. Smith
AOS
$8.61B
| $2.83M | 0.01% |
+57,400
| New | +$2.68M |
|
1634
Allegiant Air
ALGT
$2.66B
| $2.83M | 0.01% |
21,418
-2,558
| -11% | -$348K |
|
|
HAR
1635
PUT
DELISTED
Harman International Industries
HAR
| $2.82M | 0.01% |
33,400
-24,300
| -42% | -$1.99M |
|
|
EVRI
1636
DELISTED
Everi Holdings
EVRI
| $2.8M | ﹤0.01% |
1,135,145
-60,504
| -5% | -$120K |
|
1637
Terreno Realty
TRNO
$7.72B
| $2.8M | ﹤0.01% |
101,883
-52,039
| -34% | -$1.39M |
|
|
VCRA
1638
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.8M | ﹤0.01% |
165,633
-28,200
| -15% | -$431K |
|
1639
Crocs
CROX
$6.69B
| $2.8M | ﹤0.01% |
336,993
-147,017
| -30% | -$1.41M |
|
1640
Innospec
IOSP
$2.11B
| $2.8M | ﹤0.01% |
45,994
-17,330
| -27% | -$964K |
|
1641
Anika Therapeutics
ANIK
$200M
| $2.79M | ﹤0.01% |
58,310
+26,267
| +82% | +$1.3M |
|
|
EVER
1642
DELISTED
Everbank Financial Corp
EVER
| $2.79M | ﹤0.01% |
143,887
-57,802
| -29% | -$1.05M |
|
1643
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
| $2.79M | ﹤0.01% |
30,100
| – | – |
|
|
SLCA
1644
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.78M | ﹤0.01% |
+59,757
| New | +$2.33M |
|
|
PRA
1645
DELISTED
ProAssurance
PRA
| $2.78M | ﹤0.01% |
53,000
-42,486
| -44% | -$2.25M |
|
1646
Clearwater Paper
CLW
$278M
| $2.78M | ﹤0.01% |
42,965
-23,101
| -35% | -$1.46M |
|
1647
PUT
Verizon
VZ
$198B
| $2.78M | ﹤0.01% |
53,400
-593,200
| -92% | -$31.8M |
|
|
LLL
1648
DELISTED
L3 Technologies, Inc.
LLL
| $2.77M | ﹤0.01% |
18,412
-19,740
| -52% | -$2.94M |
|
|
SBNY
1649
DELISTED
Signature Bank
SBNY
| $2.77M | ﹤0.01% |
23,368
-6,823
| -23% | -$821K |
|
1650
CALL
Zions Bancorporation
ZION
$10B
| $2.75M | ﹤0.01% |
88,800
| – | – |
|
Similar funds
D.E. Shaw & Co's Q3 2016 Portfolio in Review
As of Q3 2016, D.E. Shaw & Co held 3,773 positions worth $56.7B, up 4.5% from $54.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2016 filing shows 448 new, 1,212 increased, 1,374 reduced and 429 closed positions. Its largest new stake was Dell: 13,808,231 shares worth $185M. The largest sale was Meta Platforms (Facebook), an estimated $374M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
- D.E. Shaw & Co's largest Q3 2016 buy was Dell: 13,808,231 shares worth $185M.
- D.E. Shaw & Co added most to Apple in Q3 2016, an estimated $453M increase.
- D.E. Shaw & Co's biggest Q3 2016 reduction was Meta Platforms (Facebook), cutting an estimated $374M.
- D.E. Shaw & Co fully exited EMC CORPORATION in Q3 2016, selling an estimated $278M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $56.7B portfolio in Q3 2016.
- D.E. Shaw & Co opened 448 new positions and closed 429 in Q3 2016.
- D.E. Shaw & Co's portfolio value rose 4.5% quarter-over-quarter to $56.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.